- Previous Close
29.60 - Open
30.30 - Bid 30.70 x --
- Ask 31.60 x --
- Day's Range
30.30 - 30.50 - 52 Week Range
19.36 - 32.50 - Volume
43 - Avg. Volume
8 - Market Cap (intraday)
142.123M - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
18.71 - EPS (TTM)
1.63 - Earnings Date Nov 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
www.fitlifebrands.com37
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: QO8.F
View MorePerformance Overview: QO8.F
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QO8.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QO8.F
View MoreValuation Measures
Market Cap
141.80M
Enterprise Value
151.34M
Trailing P/E
18.70
Forward P/E
14.45
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.50
Price/Book (mrq)
4.28
Enterprise Value/Revenue
2.51
Enterprise Value/EBITDA
12.57
Financial Highlights
Profitability and Income Statement
Profit Margin
13.12%
Return on Assets (ttm)
14.14%
Return on Equity (ttm)
28.59%
Revenue (ttm)
60.68M
Net Income Avi to Common (ttm)
7.96M
Diluted EPS (ttm)
1.63
Balance Sheet and Cash Flow
Total Cash (mrq)
3.68M
Total Debt/Equity (mrq)
48.22%
Levered Free Cash Flow (ttm)
-10.97M